Martin Bonde
Chief Executive Officer
Management
Vaccibody
Norway
Biography
Mr. Martin Bonde, Ph.D., B.Comm., served as the Chief Executive Officer at EpiTherapeutics ApS. Mr. Bonde served as the Chief Executive Officer of NatImmune A/S since 2004. He joined Natimmune in December 2004. He has an extensive experience from a number of different biotech companies in Denmark and the US. He founded Torsana Biosensors in 1998 and sold it to CelTor Inc. He served as an Executive Vice President of CelTor Inc. from 2000 to 2002. He served as the Chief Executive Officer of ComBio A\S from January 2003 to December 2004. He served as the Chairman of Orphazyme ApS since 2010. He serves as a Director of MycoTeQ A/S, Orphazyme ApS and Dansk Biotek - The Danish Association of Biotechnology Industries. He served as Director of Visiopharm A/S. Mr. Bonde holds a Ph.D. in Chemical Engineering from the Technical University of Denmark and a B. Comm. from Copenhagen Business School.
Research Interest
Chemical Engineering , biotechnology, Pharmaceutical sciences
